Regeneron Pharmaceuticals shares owned by Grandfield & Dodd
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Grandfield & Dodd
from 13F filings
Historical chart of Grandfield & Dodd investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Grandfield & Dodd consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Grandfield & Dodd
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $28M | 32k | 878.29 |
| 2023-09-30 | $27M | 32k | 822.96 |
| 2023-06-30 | $23M | 32k | 718.54 |
| 2023-03-31 | $25M | 31k | 821.67 |
| 2022-12-31 | $22M | 31k | 721.49 |
| 2022-09-30 | $21M | 30k | 688.76 |
| 2022-06-30 | $17M | 29k | 590.97 |
| 2022-03-31 | $20M | 29k | 698.55 |
| 2021-12-31 | $18M | 28k | 631.36 |
| 2021-09-30 | $16M | 26k | 605.05 |
| 2021-06-30 | $12M | 22k | 558.33 |
| 2021-03-31 | $8.8M | 19k | 473.01 |
| 2020-12-31 | $8.6M | 18k | 483.24 |
| 2020-09-30 | $9.3M | 17k | 559.69 |
| 2020-06-30 | $10M | 17k | 623.61 |
| 2020-03-31 | $8.3M | 17k | 488.29 |
| 2019-12-31 | $6.0M | 16k | 375.51 |
| 2019-09-30 | $3.8M | 14k | 277.37 |
| 2019-06-30 | $3.6M | 12k | 312.98 |
| 2019-03-31 | $3.7M | 9.0k | 410.67 |
| 2018-12-31 | $3.2M | 8.7k | 373.55 |
| 2018-09-30 | $2.9M | 7.2k | 404.02 |
| 2018-06-30 | $2.0M | 5.8k | 345.02 |
| 2018-03-31 | $842k | 2.4k | 344.38 |
| 2017-12-31 | $652k | 1.7k | 376.01 |
| 2017-09-30 | $736k | 1.6k | 446.87 |
| 2017-06-30 | $752k | 1.5k | 490.86 |
| 2017-03-31 | $580k | 1.5k | 387.44 |
| 2016-12-31 | $543k | 1.5k | 366.89 |
| 2016-09-30 | $523k | 1.3k | 402.31 |
| 2016-06-30 | $410k | 1.2k | 348.94 |
| 2016-03-31 | $406k | 1.1k | 360.25 |
| 2015-12-31 | $423k | 780 | 542.31 |
| 2015-09-30 | $313k | 673 | 465.08 |
| 2015-06-30 | $357k | 699 | 510.73 |
| 2015-03-31 | $335k | 742 | 451.48 |
| 2014-12-31 | $304k | 742 | 409.70 |
| 2014-09-30 | $268k | 742 | 361.19 |
| 2014-06-30 | $204k | 722 | 282.55 |
| 2014-03-31 | $203k | 677 | 299.85 |